ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional

NRX-101 for Bipolar Depression With Subacute Suicidal Ideation

ClinicalTrials.gov ID: NCT03395392

Public ClinicalTrials.gov record NCT03395392. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 6:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind Controlled Comparison of NRX-101 to Lurasidone for Adults With Bipolar Depression and Subacute Suicidal Ideation or Behavior

Study identification

NCT ID
NCT03395392
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
NeuroRx, Inc.
Industry
Enrollment
74 participants

Conditions and interventions

Interventions

  • Lurasidone HCl Drug
  • NRX-101 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 11, 2022
Primary completion
Feb 27, 2024
Completion
Mar 29, 2024
Last update posted
May 7, 2024

2022 – 2024

United States locations

U.S. sites
14
U.S. states
8
U.S. cities
13
Facility City State ZIP Site status
Science 37 Culver City California 90320
San Marcus Research Clinic, Inc. Miami Lakes Florida 33014
ACMR Atlanta Georgia 30331
iResearch Atlanta, LLC Decatur Georgia 30030
iResearch Savannah Savannah Georgia 31405
CBH Health Gaithersburg Maryland 20877
Omaha Insomnia and Psychiatric Services Omaha Nebraska 68144
Dent Neurologic Institute Amherst New York 14226
Peace Health Medical Group Eugene Oregon 97401
University of Texas Health Austin Austin Texas 78712
Roots Behavioral Health Austin Texas 78746
JPS Health Fort Worth Texas 76104
Houston Mind and Brain Houston Texas 77055
Health Texas Richmond Texas 77407

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03395392, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 7, 2024 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03395392 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →